Generic name:calcipotriene and betamethasone dipropionate
Dosage form: cream
Drug class:Topical antipsoriatics
Medically reviewed by Drugs.com. Last updated on Dec 1, 2021.
On This Page
- Indications and Usage
- Dosage and Administration
- Dosage Forms and Strengths
- Contraindications
- Warnings and Precautions
- Adverse Reactions/Side Effects
- Use In Specific Populations
- Description
- Clinical Pharmacology
- Nonclinical Toxicology
- Clinical Studies
- How Supplied/Storage and Handling
- Patient Counseling Information
Indications and Usage for Wynzora Cream
Wynzora Cream is indicated for the topical treatment of plaque psoriasis in patients 18 years of age and older.
Wynzora Cream Dosage and Administration
Apply Wynzora Cream to affected areas once daily for up to 8 weeks. Rub in gently to ensure that the plaques are saturated with the cream.
Do not use more than 100 g per week.
Discontinue therapy when control is achieved.
Do not use:
- with occlusive dressings unless directed by a healthcare provider
- on the face, groin, or axillae, or if skin atrophy is present at the treatment site
Wynzora Cream is not for oral, ophthalmic, or intravaginal use.
Dosage Forms and Strengths
Cream: 0.005%/0.064%.
Each gram of Wynzora Cream contains 50 mcg of calcipotriene and 0.644 mg of ...
